BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) | Rumor.io

ProShares UltraShort Nasdaq Biotechnology

BIS

Attention (50-day avg)0%

Attention rank (50-day avg)#1,587

Bullish sentiment (50-day avg)0%

Price to earnings ratio0

Net assets0

Expense ratio0.01%

Social

What share of all ETF conversation is about BIS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0.02% +0.02

May 28

The BIS may give XRP a top-level asset category, potentially increasing its value and adoption by institutions.
This could lead to XRP being held as collateral by central banks, funds, and institutions, revaluing its price institutionally.
The BIS's potential move would significantly impact the XRP narrative, overshadowing its current market status.

Generated by AI

Sentiment

Of the messages about BIS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	0.08% -21.52
Bearish	—	—	—	99.92% +21.52

Bullish· Apr 18

The BIS ratio's 8% capital requirement for loan assets is a regulatory safeguard that helps prevent excessive risk-taking by banks.
The BIS ratio's influence on bank lending practices is a key factor in maintaining financial stability and preventing excessive risk in the banking system.
The BIS ratio's requirement for banks to hold 8% of their loan assets as capital can help trigger a stock market rally by reducing the risk of bank failures and maintaining confidence in the financial system.

Bearish· Jul 6

US trade policy risks triggering a global financial panic, according to the BIS, which warns that tariffs could lead to supply chain disruptions and declining productivity growth.
Slower economic growth and trade shocks could lead to lower investor confidence, potentially causing a cascade of sell-offs, currency pressure, and even a financial crisis.
The BIS' bearish outlook on global trade and economic growth suggests that investors could demand higher interest rates, particularly in the US Treasury market, which could have far-reaching consequences.

Generated by AI

Topics

Of the messages about BIS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	—	—	100%	0.09%
Macro	—	—	0%	99.91%

Macro· Jul 6

BIS warns that US trade policy risks global financial panic and trade fragmentation, potentially exacerbating decline in productivity growth and supply chain pressure.
The BIS suggests that slower growth and trade shocks could lead to lower investor confidence, potentially triggering a cascade of sell-offs, currency pressure, and even a financial crisis.
The organization's comments highlight the risk of bond market meltdown in a "fragmented world economy," where governments already owe trillions and confidence breaks could have significant consequences.

Technical Analysis· Feb 24

The ProShares UltraShort Nasdaq Biotechnology (BIS) is a popular choice for investors looking to short the biotech sector.
The asset's price movement is closely tied to the performance of the Nasdaq Biotechnology Index, making it a useful tool for traders looking to capitalize on sector trends.
Technical analysts may find BIS's price action and trading volume to be particularly interesting, as they can provide insights into market sentiment and potential areas of support and resistance.

Generated by AI

Community

Of the messages about BIS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	1.24%
Newcomers	—	—	100%	98.76%

Regulars· Jan 16

The regulars are discussing the ProShares UltraShort NASDAQ Biotechnology ETF ($BIS) in relation to XIV, a volatility ETF, and other leveraged funds.
The regulars are analyzing the open price of $BIS, comparing it to other stocks such as SUNCLAYLTD.IN and EWG.
The regulars are discussing the potential of $BIS to perform well, citing stocks like CELG and LNKD as examples.

Newcomers· Jul 6

The BIS warns that US tariffs could lead to a global financial panic, causing supply chains to come under pressure and reducing productivity growth.
The BIS's warning about a potential financial crisis is based on its concerns about slower growth, trade shocks, and lower investor confidence, which could lead to a cascade of sell-offs and currency pressure.
Some commentators question the BIS's credibility, with one suggesting that it may be using its warnings to initiate a global financial panic, and another asking for proof of the BIS's financial position in the bond market.

Generated by AI

Also Discussed

Investors talking about BIS also mention

#	Name	Attention
1	ProShares Ultra Nasdaq BiotechnologyBIB	0%new
2	The Brink's CompanyBCO	0%0
3	Direxion Daily S&P Biotech Bear 3X SharesLABD	0.01%+0.01
4	Arrow Electronics Inc.ARW	0%+0
5	CHX - ChampionX Corporation	——
6	iShares Biotechnology ETFIBB	0.01%0
7	VanEck Biotech ETFBBH	0%new
8	Vanguard Small-Cap Growth ETFVBK	0%new
9	Direxion Daily Energy Bear 2X SharesERY	0%new
10	MUE - BlackRock MuniHoldings Quality Fund II, Inc.	——

ProShares UltraShort Nasdaq Biotechnology

ProShares UltraShort Nasdaq Biotechnology is an inverse exchange-traded fund designed to provide daily investment results that correspond to twice the opposite performance of the Nasdaq Biotechnology Index. The fund uses derivatives and other financial instruments to create short exposure to biotechnology, pharmaceutical, and related life sciences companies, making it a tactical product for expressing a bearish view on that segment. Its underlying benchmark includes a broad mix of Nasdaq-listed firms involved in drug development, biotech research, and healthcare innovation. ProShares UltraShort Nasdaq Biotechnology is structured around daily reset mechanics, which means its performance objective is intended for short-term use rather than long holding periods. It plays a specialized role in the market as a hedging and trading tool for investors seeking inverse exposure to the biotechnology industry.

Location

United States

Social

What share of all ETF conversation is about BIS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0.02% +0.02

May 28

The BIS may give XRP a top-level asset category, potentially increasing its value and adoption by institutions.
This could lead to XRP being held as collateral by central banks, funds, and institutions, revaluing its price institutionally.
The BIS's potential move would significantly impact the XRP narrative, overshadowing its current market status.

Generated by AI

Sentiment

Of the messages about BIS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	0.08% -21.52
Bearish	—	—	—	99.92% +21.52

Bullish· Apr 18

The BIS ratio's 8% capital requirement for loan assets is a regulatory safeguard that helps prevent excessive risk-taking by banks.
The BIS ratio's influence on bank lending practices is a key factor in maintaining financial stability and preventing excessive risk in the banking system.
The BIS ratio's requirement for banks to hold 8% of their loan assets as capital can help trigger a stock market rally by reducing the risk of bank failures and maintaining confidence in the financial system.

Bearish· Jul 6

US trade policy risks triggering a global financial panic, according to the BIS, which warns that tariffs could lead to supply chain disruptions and declining productivity growth.
Slower economic growth and trade shocks could lead to lower investor confidence, potentially causing a cascade of sell-offs, currency pressure, and even a financial crisis.
The BIS' bearish outlook on global trade and economic growth suggests that investors could demand higher interest rates, particularly in the US Treasury market, which could have far-reaching consequences.

Generated by AI

Topics

Of the messages about BIS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	—	—	100%	0.09%
Macro	—	—	0%	99.91%

Macro· Jul 6

BIS warns that US trade policy risks global financial panic and trade fragmentation, potentially exacerbating decline in productivity growth and supply chain pressure.
The BIS suggests that slower growth and trade shocks could lead to lower investor confidence, potentially triggering a cascade of sell-offs, currency pressure, and even a financial crisis.
The organization's comments highlight the risk of bond market meltdown in a "fragmented world economy," where governments already owe trillions and confidence breaks could have significant consequences.

Technical Analysis· Feb 24

The ProShares UltraShort Nasdaq Biotechnology (BIS) is a popular choice for investors looking to short the biotech sector.
The asset's price movement is closely tied to the performance of the Nasdaq Biotechnology Index, making it a useful tool for traders looking to capitalize on sector trends.
Technical analysts may find BIS's price action and trading volume to be particularly interesting, as they can provide insights into market sentiment and potential areas of support and resistance.

Generated by AI

Community

Of the messages about BIS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	1.24%
Newcomers	—	—	100%	98.76%

Regulars· Jan 16

The regulars are discussing the ProShares UltraShort NASDAQ Biotechnology ETF ($BIS) in relation to XIV, a volatility ETF, and other leveraged funds.
The regulars are analyzing the open price of $BIS, comparing it to other stocks such as SUNCLAYLTD.IN and EWG.
The regulars are discussing the potential of $BIS to perform well, citing stocks like CELG and LNKD as examples.

Newcomers· Jul 6

The BIS warns that US tariffs could lead to a global financial panic, causing supply chains to come under pressure and reducing productivity growth.
The BIS's warning about a potential financial crisis is based on its concerns about slower growth, trade shocks, and lower investor confidence, which could lead to a cascade of sell-offs and currency pressure.
Some commentators question the BIS's credibility, with one suggesting that it may be using its warnings to initiate a global financial panic, and another asking for proof of the BIS's financial position in the bond market.

Generated by AI

ProShares UltraShort Nasdaq Biotechnology

Social

May 28

Sentiment

Bullish· Apr 18

Bearish· Jul 6

Topics

Macro· Jul 6

Technical Analysis· Feb 24

Community

Regulars· Jan 16

Newcomers· Jul 6

Also Discussed

ProShares UltraShort Nasdaq Biotechnology

Company Information

Location

Also Discussed

Social

May 28

Sentiment

Bullish· Apr 18

Bearish· Jul 6

Topics

Macro· Jul 6

Technical Analysis· Feb 24

Community

Regulars· Jan 16

Newcomers· Jul 6